0001644338-21-000002.txt : 20210324 0001644338-21-000002.hdr.sgml : 20210324 20210324162012 ACCESSION NUMBER: 0001644338-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210324 DATE AS OF CHANGE: 20210324 EFFECTIVENESS DATE: 20210324 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vigeo Therapeutics, Inc. CENTRAL INDEX KEY: 0001644338 IRS NUMBER: 461204256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393410 FILM NUMBER: 21768431 BUSINESS ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-571-6800 MAIL ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0708 D LIVE 0001644338 Vigeo Therapeutics, Inc. 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 617-571-6800 DELAWARE None None Corporation true Jing Watnick 86 Sherman Strefet Cambridge MA MASSACHUSETTS 02140 Executive Officer Director Peter B. Finn 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer James E. Mahoney 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Westerly Nolin, Ph.D. 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Stephanie O'Brien 86 Sherman Street Cambridge MA MASSACHUSETTS 02140 Director Biotechnology Decline to Disclose 06b false 2021-03-15 false true false 7580137 7580137 7580137 0 false 1 0 0 0 false Vigeo Therapeutics, Inc. PETER B. FINN PETER B FINN SECRETARY 2021-03-24